Ann: LBT Strengthens APAS Pharma Development, page-6

I understand your frustration, I really do.

But this is the one time they are announcing price sensitive and serious stuff. Maybe you don't know the market that deep to understand the implications of this announcement, and so the SP is still low. I wouldn't imagine TF and BP going ahead with partnerships with a company going into suspension. If they are heading that way, time for you to sell mate.

I remain positive on the longer term, though my frustrations for the current performance are still with me, and will be hard to leave behind.

But use this Christmas break to read about the market potential, big pharma, and what the company can achieve then

GLTAH